title: Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.
authors.affiliation: Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
authors.forename: O
authors.identifier: 0000-0002-8058-3095
authors.initials: O
authors.lastname: Yélamos
authors.affiliation: Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
authors.forename: A C
authors.initials: AC
authors.lastname: Halpern
authors.affiliation: Center for Dermatoepidemiology, Veterans Affairs Medical Center, Providence, RI, U.S.A.|Department of Dermatology, Rhode Island Hospital, Providence, RI, U.S.A.|Departments of Dermatology and Epidemiology, Brown University, Providence, RI, U.S.A.
authors.forename: M A
authors.initials: MA
authors.lastname: Weinstock
mesh_terms: D018890:Chemoprevention; D006801:Humans; D016030:Kidney Transplantation; D009536:Niacinamide; D012878:Skin Neoplasms / Q000517:prevention & control; D066027:Transplant Recipients
chemical_list: D009536:Niacinamide